139 related articles for article (PubMed ID: 35299287)
1. Finding a consensus on time-to-event endpoints definitions in marginal zone lymphoma: A Delphi method.
Bommier C; Lambert J; Nowakowski G; Zucca E; Thieblemont C
Hematol Oncol; 2022 Dec; 40(5):1086-1089. PubMed ID: 35299287
[TBL] [Abstract][Full Text] [Related]
2. Systematic review reveals urgent need to homogenize endpoints choices and definitions in marginal zone lymphomas trials.
Bommier C; Ruggiu M; Monégier A; Zucca E; Thieblemont C; Lambert J
Leuk Lymphoma; 2022 Jul; 63(7):1544-1555. PubMed ID: 35201907
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.
Bellera CA; Penel N; Ouali M; Bonvalot S; Casali PG; Nielsen OS; Delannes M; Litière S; Bonnetain F; Dabakuyo TS; Benjamin RS; Blay JY; Bui BN; Collin F; Delaney TF; Duffaud F; Filleron T; Fiore M; Gelderblom H; George S; Grimer R; Grosclaude P; Gronchi A; Haas R; Hohenberger P; Issels R; Italiano A; Jooste V; Krarup-Hansen A; Le Péchoux C; Mussi C; Oberlin O; Patel S; Piperno-Neumann S; Raut C; Ray-Coquard I; Rutkowski P; Schuetze S; Sleijfer S; Stoeckle E; Van Glabbeke M; Woll P; Gourgou-Bourgade S; Mathoulin-Pélissier S
Ann Oncol; 2015 May; 26(5):865-872. PubMed ID: 25070543
[TBL] [Abstract][Full Text] [Related]
4. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure.
Harmsen MJ; Van den Bosch T; de Leeuw RA; Dueholm M; Exacoustos C; Valentin L; Hehenkamp WJK; Groenman F; De Bruyn C; Rasmussen C; Lazzeri L; Jokubkiene L; Jurkovic D; Naftalin J; Tellum T; Bourne T; Timmerman D; Huirne JAF
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):118-131. PubMed ID: 34587658
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).
Bonnetain F; Bonsing B; Conroy T; Dousseau A; Glimelius B; Haustermans K; Lacaine F; Van Laethem JL; Aparicio T; Aust D; Bassi C; Berger V; Chamorey E; Chibaudel B; Dahan L; De Gramont A; Delpero JR; Dervenis C; Ducreux M; Gal J; Gerber E; Ghaneh P; Hammel P; Hendlisz A; Jooste V; Labianca R; Latouche A; Lutz M; Macarulla T; Malka D; Mauer M; Mitry E; Neoptolemos J; Pessaux P; Sauvanet A; Tabernero J; Taieb J; van Tienhoven G; Gourgou-Bourgade S; Bellera C; Mathoulin-Pélissier S; Collette L
Eur J Cancer; 2014 Nov; 50(17):2983-93. PubMed ID: 25256896
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.
Gourgou-Bourgade S; Cameron D; Poortmans P; Asselain B; Azria D; Cardoso F; A'Hern R; Bliss J; Bogaerts J; Bonnefoi H; Brain E; Cardoso MJ; Chibaudel B; Coleman R; Cufer T; Dal Lago L; Dalenc F; De Azambuja E; Debled M; Delaloge S; Filleron T; Gligorov J; Gutowski M; Jacot W; Kirkove C; MacGrogan G; Michiels S; Negreiros I; Offersen BV; Penault Llorca F; Pruneri G; Roche H; Russell NS; Schmitt F; Servent V; Thürlimann B; Untch M; van der Hage JA; van Tienhoven G; Wildiers H; Yarnold J; Bonnetain F; Mathoulin-Pélissier S; Bellera C; Dabakuyo-Yonli TS
Ann Oncol; 2015 May; 26(5):873-879. PubMed ID: 25725046
[TBL] [Abstract][Full Text] [Related]
7. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary.
Frew JW; Lowes MA; Goldfarb N; Butt M; Piguet V; O'Brien E; Ingram J; Jemec GBE; Tan J; Zouboulis C; Alavi A; Kirby JS
JAMA Dermatol; 2021 Apr; 157(4):449-455. PubMed ID: 33688910
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative.
Cohen R; Vernerey D; Bellera C; Meurisse A; Henriques J; Paoletti X; Rousseau B; Alberts S; Aparicio T; Boukovinas I; Gill S; Goldberg RM; Grothey A; Hamaguchi T; Iveson T; Kerr R; Labianca R; Lonardi S; Meyerhardt J; Paul J; Punt CJA; Saltz L; Saunders MP; Schmoll HJ; Shah M; Sobrero A; Souglakos I; Taieb J; Takashima A; Wagner AD; Ychou M; Bonnetain F; Gourgou S; Yoshino T; Yothers G; de Gramont A; Shi Q; André T;
Eur J Cancer; 2020 May; 130():63-71. PubMed ID: 32172199
[TBL] [Abstract][Full Text] [Related]
9. Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials.
Bellera CA; Pulido M; Gourgou S; Collette L; Doussau A; Kramar A; Dabakuyo TS; Ouali M; Auperin A; Filleron T; Fortpied C; Le Tourneau C; Paoletti X; Mauer M; Mathoulin-Pélissier S; Bonnetain F
Eur J Cancer; 2013 Mar; 49(4):769-81. PubMed ID: 23122780
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.
Kramar A; Negrier S; Sylvester R; Joniau S; Mulders P; Powles T; Bex A; Bonnetain F; Bossi A; Bracarda S; Bukowski R; Catto J; Choueiri TK; Crabb S; Eisen T; El Demery M; Fitzpatrick J; Flamand V; Goebell PJ; Gravis G; Houédé N; Jacqmin D; Kaplan R; Malavaud B; Massard C; Melichar B; Mourey L; Nathan P; Pasquier D; Porta C; Pouessel D; Quinn D; Ravaud A; Rolland F; Schmidinger M; Tombal B; Tosi D; Vauleon E; Volpe A; Wolter P; Escudier B; Filleron T;
Ann Oncol; 2015 Dec; 26(12):2392-8. PubMed ID: 26371288
[TBL] [Abstract][Full Text] [Related]
11. Surgical Procedural Definitions for Hidradenitis Suppurativa Developed by Expert Delphi Consensus.
Bui H; Bechara FG; George R; Goldberg S; Hamzavi I; Kirby JS; Saylor D; Sayed CJ
JAMA Dermatol; 2023 Apr; 159(4):441-447. PubMed ID: 36811866
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Yoon DH; Yang DH; Lee WS; Kim HJ; Yhim HY; Jeong SH; Won JH; Lee S; Kong JH; Lim SN; Ji JH; Kwon KA; Lee GW; Lee JH; Lee HS; Shin HJ; Suh C
Cancer Commun (Lond); 2019 Oct; 39(1):58. PubMed ID: 31619290
[TBL] [Abstract][Full Text] [Related]
13. Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.
Moossdorff M; van Roozendaal LM; Strobbe LJ; Aebi S; Cameron DA; Dixon JM; Giuliano AE; Haffty BG; Hickey BE; Hudis CA; Klimberg VS; Koczwara B; Kühn T; Lippman ME; Lucci A; Piccart M; Smith BD; Tjan-Heijnen VC; van de Velde CJ; Van Zee KJ; Vermorken JB; Viale G; Voogd AC; Wapnir IL; White JR; Smidt ML
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25381395
[TBL] [Abstract][Full Text] [Related]
14. Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists.
Methy N; Bedenne L; Bonnetain F
BMC Cancer; 2010 Jun; 10():277. PubMed ID: 20537166
[TBL] [Abstract][Full Text] [Related]
15. Systematic reviews and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: mortality, morbidity, and organ failure.
Jackson AIR; Boney O; Pearse RM; Kurz A; Cooper DJ; van Klei WA; Cabrini L; Miller TE; Moonesinghe SR; Myles PS; Grocott MPW;
Br J Anaesth; 2023 Apr; 130(4):404-411. PubMed ID: 36697275
[TBL] [Abstract][Full Text] [Related]
16. [Gaining consensus on key terms in community health activities: A national survey using the Delphi method].
Nagai T; Umeda M; Asahara K; Mitsumori Y; Endo N; Egawa Y; Kobayashi M; Saeki K; Omori J; Shimazu T; Kawasaki C; Nagata S; Sagawa K; Konishi M
Nihon Koshu Eisei Zasshi; 2021 Aug; 68(8):538-549. PubMed ID: 34121057
[TBL] [Abstract][Full Text] [Related]
17. Defining definitions: a Delphi study to develop a core outcome set for conditions of severe maternal morbidity.
Schaap T; Bloemenkamp K; Deneux-Tharaux C; Knight M; Langhoff-Roos J; Sullivan E; van den Akker T;
BJOG; 2019 Feb; 126(3):394-401. PubMed ID: 28755459
[TBL] [Abstract][Full Text] [Related]
18. eStablish And Formalize Expert Criteria for Avoidable Resuscitation Review (SAFECARR) Electronic Delphi: Development of a Consensus Framework for Classifying and Reviewing Cardiac Arrests Within the PICU.
Dewan M; O'Halloran A; Kleinman M; Tegtmeyer K; Gallagher R; Nadkarni V; Sutton RM; Wolfe HA
Pediatr Crit Care Med; 2020 Nov; 21(11):992-999. PubMed ID: 32701751
[TBL] [Abstract][Full Text] [Related]
19. UK consensus definitions for necrotising otitis externa: a Delphi study.
Hodgson SH; Khan MM; Patrick-Smith M; Martinez-Devesa P; Stapleton E; Williams OM; Pretorius P; McNally M; Andersson MI;
BMJ Open; 2023 Feb; 13(2):e061349. PubMed ID: 36806133
[TBL] [Abstract][Full Text] [Related]
20. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
